An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives.

  1. Iaxx, R, Lefort, F, Domblides, C, Ravaud, A, Bernhard, JC, Gross-Goupil, M et al.. An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives. Ther Clin Risk Manag. 2022;18 :619-632. doi: 10.2147/TCRM.S251673. PubMed PMID:35677148 PubMed Central PMC9169675.
Search PubMed

People Involved

All right reserved © immunoconcept.cnrs.fr 2022 by Nivo-Web

Scroll to Top